Invus Public Equities, L.P. 13D/13G Filings for Rani Therapeutics Holdings, Inc. (RANI)

Invus Public Equities, L.P. 13D and 13G filings for Rani Therapeutics Holdings, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-23
5:05 pm
Purchase
2025-10-1613GRani Therapeutics Holdings, Inc.
RANI
Invus Public Equities, L.P.9,825,911
9.990%
9,825,911increase
(New Position)
Filing